Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer
Fig 1
Kaplan-Meier analyses for disease-specific survival of all 661 patients with breast cancer according to the preoperative systemic inflammatory markers.
An elevated neutrophil-lymphocyte ratio (NLR) (A), derived neutrophil-lymphocyte ratio (dNLR) (B), and platelet-lymphocyte ratio (PLR) (C) predicted poor disease-specific survival following surgical resection. A low lymphocyte-monocyte ratio (LMR) (D) predicted poor disease-specific survival.